免疫系统
癌症研究
髓样
细胞毒性T细胞
免疫学
血小板生成素
髓源性抑制细胞
血小板
生物
化学
造血
细胞生物学
医学
内科学
抑制器
干细胞
癌症
体外
生物化学
作者
Lingjun Wang,Haoyi Wang,Mingfang Zhu,Xiaofei Ni,Lu Sun,Wanru Wang,Jie Xie,Yubin Li,Yitong Xu,Ruting Wang,Shouqing Han,Ping Zhang,Jun Peng,Ming Hou,Yu Hou
出处
期刊:Blood
[Elsevier BV]
日期:2024-04-04
卷期号:144 (1): 99-112
被引量:51
标识
DOI:10.1182/blood.2023022738
摘要
ABSTRACT: Platelet α-granules are rich in transforming growth factor β1 (TGF-β1), which is associated with myeloid-derived suppressor cell (MDSC) biology. Responders to thrombopoietin receptor agonists (TPO-RAs) revealed a parallel increase in the number of both platelets and MDSCs. Here, anti-CD61 immune-sensitized splenocytes were transferred into severe combined immunodeficient mice to establish an active murine model of immune thrombocytopenia (ITP). Subsequently, we demonstrated that TPO-RAs augmented the inhibitory activities of MDSCs by arresting plasma cells differentiation, reducing Fas ligand expression on cytotoxic T cells, and rebalancing T-cell subsets. Mechanistically, transcriptome analysis confirmed the participation of TGF-β/Smad pathways in TPO-RA-corrected MDSCs, which was offset by Smad2/3 knockdown. In platelet TGF-β1-deficient mice, TPO-RA-induced amplification and enhanced suppressive capacity of MDSCs was waived. Furthermore, our retrospective data revealed that patients with ITP achieving complete platelet response showed superior long-term outcomes compared with those who only reach partial response. In conclusion, we demonstrate that platelet TGF-β1 induces the expansion and functional reprogramming of MDSCs via the TGF-β/Smad pathway. These data indicate that platelet recovery not only serves as an end point of treatment response but also paves the way for immune homeostasis in immune-mediated thrombocytopenia.
科研通智能强力驱动
Strongly Powered by AbleSci AI